Mayne Pharma Group Limited

Mayne Pharma Group Limited

World Rank (Jan-05-2024)
15,170
Market Cap (Jan-05-2024)
0.330 Billion USD
World Rank (Jul-30-2023)
16,430
Market Cap (Jul-30-2023)
0.271 Billion USD
World Rank (Jan-07-2022)
15,505
Market Cap (Jan-07-2022)
0.361 Billion USD
Headquarters Country
Australia
World Region
Oceania
World Subregion
Australia and New Zealand
Business Sector
Healthcare
Pharmaceutical
Company Website
MAYNE PHARMA GROUP LIMITED
Company Profile
Mayne Pharma Group Ltd is an ASX listed specialty pharmaceutical company focused on commercializing branded and generic pharmaceuticals. The company annual revenue is 400.3 million EUR, annual operating income is 21.3 million EUR and total assets are 1,463 million EUR as on 2021. The headquarters is in Australia.
Stock Exchange
ASX

Share